Latest news
{{'2026-06-03T06:00:52Z' | dateFormatFilter}}
Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care
{{'2026-05-27T13:00:00Z' | dateFormatFilter}}
Novo Nordisk advances cardiometabolic pipeline with new data featuring CagriSema and zenagamtide at the American Diabetes Association’s 2026 Scientific Sessions
{{'2026-05-26T08:41:00Z' | dateFormatFilter}}
Novo Nordisk global observational study reveals 2 in 5 people with cardiovascular disease have cardiovascular inflammation, increasing their risk of heart attack and stroke
Investors
Share price
{{priceData.date}} {{priceData.time}}
{{priceData.currentPrice}}
{{priceData.currency}}
Go to stock watch
{{priceData.change}} {{priceData.currency}}
